We showed previously that the levels of type I regulatory subunit of cyclic AMP-dependent protein kinase increase during differentiation of L6 skeletal myoblasts as a result of a specific decrease in its rate of degradation. Studies on the rates of degradation of the catalytic subunit show that unlike the type I regulatory subunit, catalytic subunit is degraded very slowly in myoblasts (t1/2 = 29 h) and more rapidly in myotubes (t1/2 = 14 h). As with the regulatory subunit, the degradation of catalytic subunit is increased by treatment of myoblasts with cyclic AMP analogues. These results suggest that the overall increase in the amount of type I cyclic AMP-dependent protein kinase holoenzyme during myogenesis is due to the increase in levels of mRNA for the catalytic subunit. This probably leads to an increase in the amount of catalytic subunit, which then stabilizes the regulatory subunit, thereby causing an increase in the levels of this protein also.
Skip Nav Destination
Follow us on Twitter @Biochem_Journal
Article navigation
November 1989
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkAdvertising
Research Article|
November 15 1989
Regulation of cyclic AMP-dependent protein kinase levels during skeletal myogenesis
I A J Lorimer;
I A J Lorimer
1Department of Biochemistry, University of Western Ontario, London, Ontario, Canada N6A 5C1
Search for other works by this author on:
B D Sanwal
B D Sanwal
1Department of Biochemistry, University of Western Ontario, London, Ontario, Canada N6A 5C1
Search for other works by this author on:
Publisher: Portland Press Ltd
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© 1989 London: The Biochemical Society
1989
Biochem J (1989) 264 (1): 305–308.
Citation
I A J Lorimer, B D Sanwal; Regulation of cyclic AMP-dependent protein kinase levels during skeletal myogenesis. Biochem J 15 November 1989; 264 (1): 305–308. doi: https://doi.org/10.1042/bj2640305
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |